Anavex Life Sciences(AVXL)
$0.72-0.02 (-2.84%)
AVXL
Anavex Life Sciences ownership
$0.72
At close:-0.02 (-2.84%)
Want to see AVXL full AI Analyst Report?
Anavex Life Sciences (AVXL) Ownership - Who Owns Anavex Life Sciences?
1,758 Followers
Anavex Life Sciences (AVXL) Ownership Overview
- 1.66% Insiders
- 10.55% Mutual Funds
- 13.27% Other Institutional Investors
- 11.44% ETFs
- 63.07% Public Companies and Individual Investors
The ownership structure of Anavex Life Sciences (AVXL) stock is a mix of institutional, retail, and individual investors. Approximately 35.27% of the company’s stock is owned by Institutional Investors, 1.66% is owned by Insiders, and 63.07% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Anavex Life Sciences (AVXL) stock is a mix of institutional, retail, and individual investors. Approximately 35.27% of the company’s stock is owned by Institutional Investors, 1.66% is owned by Insiders, and 63.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | $16,451,177 | ||
| Sep 30, 2026 | Gmt Capital Corp | $5,462,815 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 8,144,147 | Institution | 8.79% | 5,855,642 |
| Ishares | 4,849,947 | Institution | 5.23% | 3,487,112 |
| Vanguard | 4,295,798 | Institution | 4.63% | 3,088,679 |
| Vanguard Index Funds | 3,966,953 | Institution | 4.28% | 2,852,239 |
| Thomas E. Claugus | 2,704,364 | Institution | 2.92% | 1,944,438 |
| Federated Hermes Mdt Series | 2,045,098 | Institution | 2.21% | 1,470,425 |
| Christopher Missling | 1,510,165 | Insider | 1.63% | 1,085,809 |
| Fidelity Salem Street Trust | 1,129,534 | Institution | 1.22% | 812,135 |
| Fidelity Concord Street Trust | 838,374 | Institution | 0.90% | 602,791 |
| Vanguard Scottsdale Funds | 622,810 | Institution | 0.67% | 447,800 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 3,966,953 | Institution | 4.28% | 2,852,239 |
| Federated Hermes Mdt Series | 2,045,098 | Institution | 2.21% | 1,470,425 |
| Fidelity Salem Street Trust | 1,129,534 | Institution | 1.22% | 812,135 |
| Fidelity Concord Street Trust | 838,374 | Institution | 0.90% | 602,791 |
| Vanguard Scottsdale Funds | 622,810 | Institution | 0.67% | 447,800 |
| Tiaa-cref Funds | 312,085 | Institution | 0.34% | 224,389 |
| Vanguard World Fund | 270,423 | Institution | 0.29% | 194,434 |
| Schwab Capital Trust | 224,867 | Institution | 0.24% | 161,679 |
| Bridgeway Funds, Inc. | 123,000 | Institution | 0.13% | 88,437 |
| Vanguard Valley Forge Funds | 48,976 | Institution | 0.05% | 35,214 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| iShares Russell 2000 ETF, IWM ETF | 2,430,246 | Institution | 2.62% | 1,748,319 |
| Vanguard Total Stock Market ETF, VTI ETF | 2,305,349 | Institution | 2.49% | 2,743,365 |
| Vanguard Extended Market ETF, VXF ETF | 1,081,833 | Institution | 1.17% | 1,287,381 |
| iShares Russell 2000 Value ETF, IWN ETF | 736,898 | Institution | 0.79% | 530,124 |
| iShares Biotechnology ETF, IBB ETF | 703,136 | Institution | 0.76% | 505,836 |
| Vanguard Russell 2000 ETF, VTWO ETF | 543,863 | Institution | 0.59% | 647,197 |
| Schwab U.S. Small-Cap ETF, SCHA ETF | 492,979 | Institution | 0.53% | 364,804 |
| iShares Micro-Cap ETF, IWC ETF | 279,034 | Institution | 0.30% | 200,737 |
| Vanguard Health Care ETF, VHT ETF | 271,823 | Institution | 0.29% | 323,469 |
| iShares Russell 2000 Growth ETF, IWO ETF | 204,978 | Institution | 0.22% | 147,461 |
FAQ
Who Owns Anavex Life Sciences (AVXL)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 35.27% of the company's stock is held by institutional investors, 1.66% is held by insiders, and 63.07% is held by public companies and individual investors.
What percentage of Anavex Life Sciences (AVXL) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 35.27% of Anavex Life Sciences (AVXL) stock is held by institutional investors: 10.55% by mutual funds, 11.44% by ETFs and 13.27% by other institutional investors.
What percentage of Anavex Life Sciences (AVXL) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 63.07% of Anavex Life Sciences (AVXL) stock is held by public companies and individual investors.
Who owns the most shares of Anavex Life Sciences (AVXL)?
BlackRock, Inc. owns the most shares of Anavex Life Sciences (AVXL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

